School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Turn Therapeutics Inc. TTRX

Healthcare · Biotechnology

$12.00last close 2026-10-09 · market cap $337.39M · delayed data

Trailing returns

1M-12.73%
3M+36.21%
6M+241.88%
1Y+30.43%

Basis: Adjusted daily closes.

What it does

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.

Open TTRX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies